The relationship between the insulin resistance syndrome and insulin sensitivity in the first-degree relatives of subjects with non-insulin dependent diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 42, Issue 2, 1998, Pages 91-99

  Shaw, J T E ^a   Levy, J C ^b   Turner, R C ^b  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Hyperlipidaemia; Hypertension; Impaired glucose tolerance; The insulin resistance syndrome

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ARTICLE; BODY MASS; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; FAMILIAL DISEASE; GENETIC SUSCEPTIBILITY; GLUCOSE INTOLERANCE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT;

ADULT; DIABETES MELLITUS, TYPE 2; FAMILY HEALTH; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SYNDROME;

EID: 0031797260     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(98)00099-0     Document Type: Article

References (22)

1. Barnett A.H., Eff C., Leslie R.D.G., Pyke D.A. Diabetes in identical twins: a study of 200 pairs. Diabetologia. 20:1981;87-93.
2. Newman B., Selby J.V., King M.C., Slemenda C., Fabsitz R., Friedman G.D. Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia. 30:1987;763-768.
3. Turner R.C., Hattersley A.T., Shaw J.T.E., Levy J.C. Type II diabetes: clinical aspects of molecular biological studies. Diabetes. 44:1995;1-10.
4. Defronzo R.A. Lilly Lecture 1987: the triumvirate: β-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes. 37:1988;667-687.
5. Reaven G.M. Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
6. Lillioja S., Mott D.M., Zawadzki J.K. In vivo insulin action is a familial characteristic in nondiabetic Pima Indians. Diabetes. 36:1987;1329-1335.
7. Levy J.C., Barrow B.A., Lever D.E., Morris R.I., Turner R.C. Familial association and lambda -s for diabetes, obesity, high triglycerides and low HDL-cholesterol in sibs of NIDDM patients. Diabetes. 46:1997;136A.
8. Hosker J.P., Matthews D.R., Rudenski A.S., Burnett M.A., Darling P., Bown E.G., Turner R.C. Continuous infusion of glucose with model assessment: measurement of insulin resistance and β-cell function in man. Diabetologia. 28:1985;401-411.
9. Metropolitan Life Insurance Company National weights standards for men and women. Stat. Bull. Metropolitan Life Insurance Company. 40:1959;14.
10. M.S. Hammersley, J.C. Levy, G. Volpicelli, B. Barrow, R.C. Turner, Assessment of impaired glucose tolerance and β-cell function with a continuous infusion of glucose test and an oral glucose tolerance test, Diabet. Med. 9 (Suppl. 1) (1992) 17 (Abstract).
11. Levy J.C., Rudenski A., Burnett M., Knight R., Matthews D.R., Turner R.C. Simple empirical assessment of β-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects. Diabetologia. 34:1991;488-499.
12. SAS User's Guide, Statistics Version 5 Edition, 1985.
13. World Health Organization, WHO Technical Report Series 1985, no 727.
14. I. Zavaroni, S. Mazza, L. Luchetti, G. Buonatinno, P.A. Bonati, M. Bergonzani, M. Passeri, G.M. Reaven, High plasma insulin and triglyceride concentrations and blood pressure in offspring of people with impaired glucose tolerance, Diabet. Med. 7 (1990) 494-498.
15. Laws A., Stefanick M.L., Reaven G.M. Insulin resistance and hypertriglyceridaemia in non-diabetic relatives of patients with non-insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 69:1989;343-347.
16. Stewart M.W., Humphriss D.B., Berrish T.S., Barriocanal L.A., Trajano L.R., Alberti K.G., Walker M. Features of syndrome X in first-degree relatives of NIDDM patients. Diabet. Care. 18:1995;1020-1022.
17. Clark P.M., Levy J.C., Cox L., Burnett M., Turner R.C., Hales C.N. Immunoradiometric assay to insulin, intact proinsulin and 32-33 split proinsulin and radioimmunoassay of insulin in diet-treated type 2 (non-insulin-dependent) diabetic subjects. Diabetologia. 35:1992;469-474.
18. Levy J.C., Clark P.M., Hales C.N., Turner R.C. Normal proinsulin responses to glucose in mild type 2 (non-insulin-dependent) diabetic subjects with subnormal insulin response. Diabetes. 42:1993;162-169.
19. Haffner S.M., Valdex R.A., Hazuda H.P., Mitchell B.D., Morales P.A., Stern M.P. Prospective analysis of the insulin resistance syndrome (Reaven's syndrome). Diabetes. 41:1992;715-722.
20. R.C. Turner, I.M. Stratton, C.A. Cull, R.R. Holman, for UK Prospective Diabetes Study, The high prevalence of Reaven's syndrome in newly-diagnosed type II diabetic patients and the poor response of the dyslipidaemia to hypoglycaemic therapies. International Diabetes Federation, Washington, June 1991 (Abstract).
21. Kissebah A.H., Vydelingum N., Murray R., Evans D.J., Hartz A.J., Kalkhoff R.K., Adams P.W. Relation of body fat distribution to metabolic complications of obesity. J. Clin. Endocrinol. Metab. 54:1982;254-260.
22. Moller D.E., Flier J.S. Insulin resistance - mechanisms, syndromes and implications. New Engl. J. Med. 325:1991;938-948.